Nutex Health Announces 2024 Annual Meeting of Stockholders on June 17
Ticker: NUTX · Form: DEF 14A · Filed: May 6, 2024 · CIK: 1479681
Sentiment: neutral
Topics: Annual Meeting, Proxy Statement, Reverse Stock Split, Executive Compensation, Auditor Ratification
Related Tickers: NUTX
TL;DR
Nutex Health is holding its 2024 Annual Meeting on June 17, 2024, to vote on director re-elections, executive compensation, a potential reverse stock split, and auditor ratification.
AI Summary
Nutex Health, Inc. (NUTX) filed a Proxy Statement (DEF 14A) with the SEC on May 6, 2024. Nutex Health will hold its 2024 Annual Meeting of Stockholders virtually on June 17, 2024. Key agenda items include re-electing all Board of Directors members, an advisory vote on executive compensation, and approving a reverse stock split. The proposed reverse stock split ratio will be between 1-for-2 and 1-for-16, determined by the Board. Shareholders will also vote to ratify the appointment of Marcum LLP as the independent registered public accounting firm for the year ending December 31, 2024. The meeting will be conducted online at www.virtualshareholdermeeting.com/NUTX2024.
Why It Matters
For investors and stakeholders tracking Nutex Health, Inc., this filing contains several important signals. The proposed reverse stock split could significantly alter the company's share structure and potentially impact its stock price and market perception. Shareholder approval is required for the reverse stock split and ratification of the auditor, indicating key decisions are being put to a vote.
Risk Assessment
Risk Level: medium — Nutex Health, Inc. shows moderate risk based on this filing. The company is proposing a reverse stock split, which can be a sign of efforts to meet exchange listing requirements or improve stock price perception, but can also be viewed negatively by investors if not accompanied by fundamental improvements.
Analyst Insight
Stockholders should carefully consider the implications of the proposed reverse stock split and the advisory vote on executive compensation before casting their votes.
Key Numbers
- June 17, 2024 — Annual Meeting Date (Date of the 2024 Annual Meeting of Stockholders)
- 1-for-2 to 1-for-16 — Reverse Stock Split Ratio Range (Potential range for the reverse stock split)
- December 31, 2024 — Fiscal Year End (Year for which Marcum LLP is proposed as auditor)
- 2025 — Director Term Expiration (Year director terms will expire if not re-elected)
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- June 17, 2024 (date) — Annual Meeting date
- Thomas T. Vo (person) — Board of Directors nominee
- Warren Hosseinion (person) — Board of Directors nominee
- Mitchell Creem (person) — Board of Directors nominee
- Cheryl Grenas (person) — Board of Directors nominee
- Michael L. Reed (person) — Board of Directors nominee
- Scott J. Saunders (person) — Board of Directors nominee
FAQ
When did Nutex Health, Inc. file this DEF 14A?
Nutex Health, Inc. filed this Proxy Statement (DEF 14A) with the SEC on May 6, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Nutex Health, Inc. (NUTX).
Where can I read the original DEF 14A filing from Nutex Health, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Nutex Health, Inc..
What are the key takeaways from Nutex Health, Inc.'s DEF 14A?
Nutex Health, Inc. filed this DEF 14A on May 6, 2024. Key takeaways: Nutex Health will hold its 2024 Annual Meeting of Stockholders virtually on June 17, 2024.. Key agenda items include re-electing all Board of Directors members, an advisory vote on executive compensation, and approving a reverse stock split.. The proposed reverse stock split ratio will be between 1-for-2 and 1-for-16, determined by the Board..
Is Nutex Health, Inc. a risky investment based on this filing?
Based on this DEF 14A, Nutex Health, Inc. presents a moderate-risk profile. The company is proposing a reverse stock split, which can be a sign of efforts to meet exchange listing requirements or improve stock price perception, but can also be viewed negatively by investors if not accompanied by fundamental improvements.
What should investors do after reading Nutex Health, Inc.'s DEF 14A?
Stockholders should carefully consider the implications of the proposed reverse stock split and the advisory vote on executive compensation before casting their votes. The overall sentiment from this filing is neutral.
Risk Factors
- Reverse Stock Split [medium — financial]: The company proposes to amend its certificate of incorporation to effect a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-16.
- Annual Meeting Agenda Items [low — regulatory]: The meeting will address the re-election of directors, advisory vote on executive compensation, and ratification of the independent auditor.
Key Dates
- 2024-06-17: 2024 Annual Meeting of Stockholders — Key decisions on board, compensation, stock split, and auditor to be made.
Glossary
- Reverse Stock Split
- A corporate action to reduce the number of outstanding shares of common stock by consolidating them. (May impact share price, trading volume, and investor perception.)
Filing Stats: 4,861 words · 19 min read · ~16 pages · Grade level 12.2 · Accepted 2024-05-06 16:46:16
Key Financial Figures
- $0.001 — 49,566,991 shares of our common stock, $0.001 par value per share ("common stock") ou
Filing Documents
- tm2412754d4_def14a.htm (DEF 14A) — 832KB
- lg_nutexhealth-4clr.jpg (GRAPHIC) — 9KB
- sg_thomas-bw.jpg (GRAPHIC) — 8KB
- bc_capvstsr-4c.jpg (GRAPHIC) — 48KB
- bc_capvsnetincome-4c.jpg (GRAPHIC) — 52KB
- px_nutexproxy1pg1-4c.jpg (GRAPHIC) — 223KB
- px_nutexproxy1pg2-4c.jpg (GRAPHIC) — 138KB
- 0001104659-24-057492.txt ( ) — 2670KB
- nutx-20231231.xsd (EX-101.SCH) — 9KB
- nutx-20231231_def.xml (EX-101.DEF) — 9KB
- nutx-20231231_lab.xml (EX-101.LAB) — 32KB
- nutx-20231231_pre.xml (EX-101.PRE) — 11KB
- tm2412754d4_def14a_htm.xml (XML) — 135KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 33
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 35 Pension Benefits 40 Nonqualified Deferred Compensation 40 Health and Welfare Plans 40 Tax Gross-Ups 40 Severance and Change in Control Payments and Benefits 40 Tax and Accounting Considerations 40 Securities Trading Policy 41 Compensation Recovery ("Clawback") Policy 41 Grants of Plan-Based Awards in 2023 46 Option Exercises and Stock Vested in 2023 46 i TABLE OF CONTENTS Potential Payments upon Termination or Change in Control 46 Pay Versus Performance 47 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 50 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 51 Related Person Transactions 51 Indemnification of Directors 51 Policies and Procedures for Related Person Transactions 51 DELINQUENT SECTION 16(a) REPORTS 53 STOCKHOLDER PROPOSALS 53 STOCKHOLDERS SHARING THE SAME ADDRESS 54 OTHER MATTERS 54 APPENDIX A AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NUTEX HEALTH INC. A-1 ii TABLE OF CONTENTS PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 17, 2024 The Board of Directors (the "Board") of Nutex Health Inc. ("Nutex," "the Company," "we," "us," or "our") is soliciting proxies for use at the 2024 Annual Meeting of Stockholders (the "Annual Meeting"), to be held online via the Internet as a virtual web conference at www.virtualshareholdermeeting.com/NUTX2024 on June 17, 2024 at 10:00 a.m. Central Daylight Time. We have determined that the Annual Meeting will be held in a virtual meeting format, via the Internet. At our virtual Annual Meeting, stockholders will be able to attend, vote and submit questions by visiting www.virtualshareholdermeeting. com/NUTX2024. Further information about how to attend the Annual Meeting online, vote your shares online during the Annual Meeting and submit questions during the Annual Meeti